Earkick App for Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an AI therapy chatbot app called Earkick to determine its effectiveness in assisting caregivers of people with dementia. The goal is to assess whether the app is user-friendly and beneficial for those providing emotional, physical, or financial support to individuals with dementia. The trial seeks participants who experience high caregiver stress and are comfortable using a smartphone or similar device. Participants cannot be professional, paid caregivers and must understand English, as well as be able to use the internet and text messaging. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance caregiver support.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Earkick app is safe for caregivers?
Research shows that the Earkick app is designed to help manage mental health using a personal AI chatbot. For caregivers of people with dementia, this app aims to offer support and improve well-being. As an app, it lacks the physical side effects that medications might cause.
However, potential risks with AI chatbots should be considered. Concerns include the possibility of the AI providing incorrect advice or impersonating a professional. Ongoing discussions focus on using this technology safely and responsibly.
This trial is in a "Not Applicable" phase, meaning the study evaluates the app's practicality and user experience rather than testing for safety risks as in drug trials. Consequently, limited direct safety data is available. Users should consider these points when deciding to participate.12345Why are researchers excited about this trial?
The Earkick app is unique because it offers a digital tool specifically designed for caregivers to manage their mental health and stress levels. Unlike traditional options, which may include therapy sessions or medication, this app provides real-time monitoring and personalized feedback through a smartphone, making it accessible and convenient. Researchers are excited about this treatment because it leverages technology to deliver immediate support, potentially improving caregivers' well-being more efficiently than existing methods.
What evidence suggests that the Earkick app is effective for supporting caregivers of individuals with dementia?
Research has shown that the Earkick app, which uses artificial intelligence to assist with mental health, can lower stress and boost mood. Users reported feeling 12.25% happier and experiencing 28.45% less anxiety after using the app regularly for 90 days. The app's chatbot understands emotions and offers immediate support, which can enhance overall mental well-being. Although this data is based on studies about general mental health, it suggests that Earkick could also help caregivers of people with dementia by managing their stress and emotional needs. Participants in this trial will use the Earkick app to evaluate its effectiveness specifically for caregivers.36789
Who Is on the Research Team?
Mark Newman, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for informal caregivers of individuals with dementia who feel a high level of burden, as measured by a specific questionnaire. They must speak English, have an Apple device with internet and text messaging capabilities, and be willing to download and use the Earkick AI chatbot app for the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the Earkick AI therapy chatbot application to support care partners of individuals living with dementia
Follow-up
Participants are monitored for feasibility and acceptability of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Earkick app
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor